Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Geography
Publication Month: Apr 2021 | Report Code: TIPRE00003406 | No. of Pages: 161 | Category: Pharmaceuticals | Status: Published
The antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028.
Antibiotics are powerful medicines that are used to fight against bacterial infections and diseases. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. Antibiotics either kill the bacteria (bactericidal) or restrict it from reproducing and growing (bacteriostatic). The antibiotics market do not work against any viral infection. Some of the common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat), and among others.
Lucrative Regional Antibiotics Markets
Get more information on this report :
Market Insights
Increasing Development of Generic Drugs
A generic medicine is a copy of a branded drug that is no longer under patent. Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, according to a study published on the NCBI in 2018, the average brand name prescription price was almost 4-times the average generic price. Additionally, the companies are also focusing on the development of generic versions with an aim to offer antibiotics at minimal costs. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Further, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the antibiotics market during the forecast period. For instance, in February 2019, the US Food and Drug Administration (US FDA) announced approval for commercialization of generic medicines manufactured by Indian drug companies in the US.
Test Type Insights
Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2020; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.
Global Antibiotics Market, by Product Type – 2020 & 2028
Get more information on this report :
Action-Mechanism Insights
Based on action mechanism, the antibiotics market has been segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2020, whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.
Strategic Insights
Product launches and approval strategies are commonly adopted by companies to expand their footprint and product portfolio worldwide and meet the growing demand.
The market players operating in the antibiotics market adopt the strategy of expansion to enlarge customer base across the world, which also permits the players to maintain their brand name globally. For instance, in July 2019, the company such as Pfizer has launched an international research consortium to discover and develop new TB antibiotics in collaboration with eight biotechnology partners and European academic.
Global Antibiotics Market – By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
Global Antibiotics Market – By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Global Antibiotics – By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Pfizer, Inc
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
- Abbott,
- GlaxoSmithKline Plc,
- Sanofi,
- Novartis AG,
- Bayer AG,
- Bristol Myers Squibb Company,
- Eli Lilly and Company,
- Astellas Pharma
Frequently Asked Questions
The List of Companies - Antibiotics Market
- Pfizer, Inc
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
- Abbott,
- GlaxoSmithKline Plc,
- Sanofi,
- Novartis AG,
- Bayer AG,
- Bristol Myers Squibb Company,
- Eli Lilly and Company,
- Astellas Pharma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibiotics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
